SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040651
Filing Date
2023-08-09
Accepted
2023-08-09 16:26:10
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tnya-20230630.htm   iXBRL 10-Q 2849688
2 EX-3.1 tnya-ex3_1.htm EX-3.1 74344
3 EX-31.1 tnya-ex31_1.htm EX-31.1 27347
4 EX-31.2 tnya-ex31_2.htm EX-31.2 27481
5 EX-32.1 tnya-ex32_1.htm EX-32.1 18257
  Complete submission text file 0000950170-23-040651.txt   8620804

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnya-20230630_def.xml EX-101.DEF 146680
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnya-20230630.xsd EX-101.SCH 41278
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnya-20230630_lab.xml EX-101.LAB 362305
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnya-20230630_pre.xml EX-101.PRE 263463
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnya-20230630_cal.xml EX-101.CAL 43366
54 EXTRACTED XBRL INSTANCE DOCUMENT tnya-20230630_htm.xml XML 1520806
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40656 | Film No.: 231155594
SIC: 2836 Biological Products, (No Diagnostic Substances)